Short-term, nonsurgical periodontal therapy boosts interleukin-12 levels and reduces oral cancer risk

Hazza A. Alhobeira,Anamika Sharma, Ananya Sharma,Mahvish Khan,Mohtashim Lohani,Saif Khan, Eslam K. Fahmy, Safya E. Esmaeel, Anshoo Agarwal

Irish Journal of Medical Science (1971 -)(2024)

引用 0|浏览2
暂无评分
摘要
Cytokines, including interleukin-12 (IL-12), are proteins that regulate cell survival, proliferation, differentiation, and function. IL-12 is a heterodimeric proinflammatory cytokine. It possesses tumoricidal properties and promotes M1 macrophage polarization and IFN-γ production by T helper (Th1) cells, which in turn stimulates the antitumor cytotoxic cluster of eight positive (CD8+) and natural killer cells, therefore activating an effector immune response against tumor cells. Herein, the IL-2 levels of 60 patients with generalized chronic periodontitis (GCP) were assessed. Plaque index, gingival index, pocket probing depth, bleeding on probing percentage (BOP
更多
查看译文
关键词
Chronic periodontitis,Interleukin-12,Oral cancer,Short-term nonsurgical treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要